Claris Lifesciences Ltd has been delisted from the stock exchange.
Sector
PharmaceuticalsOpen
₹395.1Prev. Close
₹396.8Turnover(Lac.)
₹499.71Day's High
₹396.9Day's Low
₹39552 Week's High
₹052 Week's Low
₹0Book Value
₹-2.13Face Value
₹10Mkt Cap (₹ Cr.)
2,163.88P/E
0EPS
0Divi. Yield
0No Record Found
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Equity Capital | 54.57 | 54.57 | 54.57 | 54.57 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -66.23 | -65.96 | -60.94 | -53.86 |
Net Worth | -11.66 | -11.39 | -6.37 | 0.71 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 122.05 |
yoy growth (%) | 0 | 0 | -100 | -83.1 |
Raw materials | 0 | 0 | 0 | -96.83 |
As % of sales | 0 | 0 | 0 | 79.34 |
Employee costs | 0 | 0 | 0 | -18.45 |
| Y/e 31 Mar( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | -4.43 | -9.92 | 1.41 | -43.32 |
Depreciation | 0 | -0.1 | -0.13 | -3.55 |
Tax paid | -2.64 | -1.71 | 0.56 | 2.29 |
Working capital | 23.12 | -456.75 | -22.15 | -40.68 |
Other operating items |
| Y/e 31 Mar | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | -100 | -83.1 |
Op profit growth | -47.93 | 124.12 | -86.81 | -190.76 |
EBIT growth | -55.35 | -801.75 | -103.58 | -129.62 |
Net profit growth | -175.83 | -19.2 | -157.02 | -114.6 |
| Particulars (Rupees in Crores.) | Mar-2017 | Mar-2016 | Mar-2015 | Dec-2014 | Dec-2013 |
|---|---|---|---|---|---|
Gross Sales | 10.43 | 133.16 | 780.11 | 625.39 | 658.38 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 10.43 | 133.16 | 780.11 | 625.39 | 658.38 |
Other Operating Income | 0 | 0 | 19.64 | 16.45 | 9.39 |
Other Income | 190 | 117.07 | 86.3 | 72.51 | 58.5 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,824.4 | 101.48 | 4,42,893.24 | 705.44 | 0.87 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,792.2 | 68.55 | 1,76,366.71 | 598 | 0.45 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,295.2 | 66.37 | 1,48,240.79 | 577 | 0.14 | 2,547 | 249.82 |
Dr Reddys Laboratories Ltd DRREDDY | 1,265.1 | 22.85 | 1,06,009.78 | -219.4 | 0.63 | 3,802.6 | 377.55 |
Cipla Ltd CIPLA | 1,327.15 | 22.78 | 1,04,365.52 | 616.88 | 1.24 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Director
SURRINDER LAL KAPUR
Managing Director
ARJUN SUSHILKUMAR HANDA
Whole-time Director
CHANDRASINGH SHIVRAMBHAI PUROHIT
Director
ANUP PRAVIN SHAH
Director
ADITYA SUSHILKUMAR HANDA
Company Secretary
KIRITKUMAR HIMATLAL KANJARIA
Director
SHYAMSUNDER KASHIRAM SHARMA
Claris Corporate Headquarters,
Ellisbridge,
Gujarat - 380006
Tel: 91-79-26563331/66309339
Website: http://www.clarislifesciences.com
Email: investorservices.corp@clarislifesciences.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Claris Lifesciences Ltd is one of the largest sterile injectables pharmaceutical companies in India with a market presence in 76 countries worldwide. The company primarily manufactures and markets pro...
Read More
Reports by Claris Lifesciences Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.